Zarodkowe komórki macierzyste, ich podobieństwo z komórkami nowotworowymi - aspekty praktyczne i perspektywy

• Autorzy: Bukowska D. , Kempisty B. , Zaorska K. , Zawierucha P. , Piotrowska H. , Nowicki M.

Warianty tytułu

EN

Similarities between embryonic stem cells and tumor cells: Practical aspects and perspectives

• Języki publikacji: PL

Abstrakty

EN

This article reviews early research on embryonic stem cells and present possibilities of their application, e.g. in anticancer therapy. It also discusses the advantages and disadvantages of applying embryonic stem cells in the treatment of selected disorders. Embryonic stem cells are characterized by pluripotency, that is, the ability to differentiate into every type of cells of a developing organism. The research of recent years has revealed considerable similarities between embryonic stem cells and cancer cells, mainly in terms of the presence of common surface antigen molecules. However, a great potential of embryonic stem cells for biomedical applications is combined with a risk of their differentiation into cancer. Research based on animal models (e.g. mouse) has shown that directed embryonic stem-cell therapy can be used in many degenerative disorders.

Słowa kluczowe

PL

komorki macierzyste; komorki macierzyste embrionalne; komorki nowotworowe; podobienstwo; pluripotencja; komorki pluripotencjalne; terapia przeciwnowotworowa

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2012
• Tom: 68
• Numer: 03
• Opis fizyczny: s.148-151,bibliogr.

Twórcy

autor

Bukowska D.

• Katedra Weterynarii, Wydział Hodowli i Biologii Zwierząt, Uniwersytet Przyrodniczy w Poznaniu, ul.Wojska Polskiego 52, 60-628 Poznań

autor

Kempisty B.

autor

Zaorska K.

autor

Zawierucha P.

autor

Piotrowska H.

autor

Nowicki M.

Bibliografia

• 1.Alexander P., Fairley G. H.: Cellular resistance to tumours. Br. Med. Bull. 1967, 23, 86-92.
• 2.Ambrose K. R., Anderson N. G., Coggin J. H.: Interruption of SV40 oncogenesis with human foetal antigen. Nature 1971, 233, 194-195.
• 3.Ambrose K. R., Anderson N. G., Coggin J. H. Jr.: Cytostatic antibody and SV40 tumour immunity in hamsters. Nature 1971, 233, 321-324.
• 4.Baldwin R. W., Glaves D., Vose B. M.: Embryonic antigen expression in chemically induced rat hepatomas and sarcomas. Int. J. Cancer 1972, 10, 233-243.
• 5.Borsos T., Richardson A. K., Ohanian S. H., Leonard E. J.: Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors. J. Natl. Cancer Inst. 1973, 51, 1955-1990.
• 6.Brawn R. J.: Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas. Int. J. Cancer 1970, 6, 245-249.
• 7.Cho M. S., Lee Y. E., Kim J. Y., Chung S., Cho Y. H., Kim D. S., Kang S. M., Lee H., Kim M. H., Kim J. H., Leem J. W., Oh S. K., Choi Y. M., Hwang D. Y., Chang J. W., Kim D. W.: Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 2008, 105, 3392-3397.
• 8.Coggin J. H., Ambrose K. R., Anderson N. G.: Fetal antigen capable of inducing transplantation immunity against SV40 hamster tumor cells. J. Immunol. 1970, 105, 524-526.
• 9.Conheim J.: Vorlesungen über allgemeine Pathologie. Ein Handbuch für Ärzte und Studirende, T. 2, Hirschwald, Berlin 1880, s. 634-654.
• 10.Conrad S., Renninger M., Hennenlotter J., Wiesner T., Just L., Bonin M., Aicher W., Bühring H. J., Mattheus U., Mack A., Wagner H. J., Minger S., Matzkies M., Reppel M., Hescheler J., Sievert K. D., Stenzl A., Skutella T.: Generation of pluripotent stem cells from adult human testis. Nature 2008, 456, 344-349.
• 11.Cowan C. A., Atienza J., Melton D. A., Eggan K.: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309, 1369-1373.
• 12.Durante F.: Nesso Fisi-patologico tra la Struttura dei Nei Materni e la Genesi di alcuni Tumori Maligni. Archivio di Memorie ed Ossevazione di Chirurgia Practica (per F. Palasciano), Gennaro a Decembre, Napoli 1874.
• 13.French A. J., Adams C. A., Anderson L. S., Kitchen J. R., Hughes M. R., Wood S. H.: Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 2008, 26, 485-493.
• 14.Gurdon J. B., Melton D. A.: Nuclear reprogramming in cells. Science 2008, 322, 1811-1815.
• 15.Hirzfeld L.: Untersuchungen über die serologischen Eigenschaften der Gewebe: über serologische Eigenschaften der Neubildungen. Z. Immun. Forsch. Exp. Ther. 1929, 64, 81-113.
• 16.Hirzfeld L., Halber U., Rosenblat J. C.: Verwandtschaftsreaktionen zwischen Embryonal- und Krebsgewebe; Mesenchenembryo und Menschenkrebs. Z. Immunitatsforsch. Exp. Ther. 1932, 75, 209-216.
• 17.Keirstead H. S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., Steward O.: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 2005, 25, 4694-4705.
• 18.Klimanskaya I., Chung Y., Becker S., Lu S. J., Lanza R.: Human embryonic stem cell lines derived from single blastomers. Nature 2006, 444, 481-485.
• 19.Laurence D. J., Neville A. M.: Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br. J. Cancer 1972, 26, 335-355.
• 20.Müller J.: Über den feineren Bau und die Formen der krankhaften Geschwülste. Reimer, Berlin 1938.
• 21.Ostrowski K.: Medycyna oparta o komórki macierzyste. Post. Hig. Med. Dośw. 2005, 59, 124-128.
• 22.Raya A., Rodriguez-Piza I., Guenechea G., Vassena R., Navarro S., Barrero M. J., Consiglio A., Castellà M., Río P., Sleep E., González F., Tiscornia G., Garreta E., Aasen T., Veiga A., Verma I. M., Surrallés J., Bueren J., Izpisúa Belmonte J. C.: Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009, 460, 53-59.
• 23.Revazova E. S., Turovets S. A., Kochetkova O. D., Kindarova L. B., Kuzmichev L. N., Janus J. D., Pryzhkova M. V.: Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2007, 9, 432-449.
• 24.Robinson J. F., Theunissen P. T., van Dartel D. A., Pennings J. L., Faustman E. M., Piersma A. H.: Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology. Reprod. Toxicol. 2011, 32, 180-188.
• 25.Savory W. S.: Bradshaw lecture on the pathology of cancer. Tracts, 172 Royal College of Surgeons of England, Churchill, London 1884, s. 38.
• 26.Schöne G.: Untersuchungen über Karzinomimmunität bei Mäusen. Münch. Med. Wschr. 1906, 51, 2517-2519.
• 27.Stonehill E. H., Bendich A.: Retrogenetic expression: the reappearance of embryonal antigens in cancer cells. Nature 1970, 228, 370-372.
• 28.Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
• 29.Takahashi K., Yamanaka S.: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
• 30.Thompson J. A., Itskovitz-Eldor J., Shapiro S. S., Waknitz M. A., Swiergiel J. J., Marshall V. S.: Embryonic stem cell lines derived from human blastocysts. Science 1988, 282, 1145-1147.
• 31.Turnpenny L., Brickwood S., Spalluto C. M., Piper K., Cameron I. T., Wilson D. I., Hanley N. A.: Derivation of human embryonic germ cells: an alternative source of pluripotent stem cells. Stem Cells 2003, 21, 598-609.
• 32.Yu J., Vodyanik M. A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J. L., Tian S., Nie J., Jonsdottir G. A., Ruotti V., Stewart R., Slukvin I. I., Thomson J. A.: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1929.